Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Wheaton Precious Metals Corp.

Start price
Target price
Perf. (%)
€35.93
24.01.22
-
24.01.23
-0.72%
05.02.22

Could be worthwhile Investment >10% per year
Future proof or reliable business model
buy
Wheaton Precious Metals Corp.

Start price
Target price
Perf. (%)
€35.93
24.01.22
-
24.01.23
-0.72%
05.02.22

Could be worthwhile Investment >10% per year
Future proof or reliable business model
buy
Barrick Gold Corp

Start price
Target price
Perf. (%)
€17.20
24.01.22
-
24.01.23
-2.31%
05.02.22

Could be worthwhile Investment >10% per year
Known brand
buy
Barrick Gold Corp

Start price
Target price
Perf. (%)
€17.20
24.01.22
-
24.01.23
-2.31%
05.02.22

Could be worthwhile Investment >10% per year
Known brand
buy
Pan American Silver Corp.

Start price
Target price
Perf. (%)
€20.94
24.01.22
-
24.01.23
-8.88%
05.02.22

Could be worthwhile Investment >10% per year
Future proof or reliable business model
buy
Pan American Silver Corp.

Start price
Target price
Perf. (%)
€20.94
24.01.22
-
24.01.23
-8.88%
05.02.22

Could be worthwhile Investment >10% per year
Future proof or reliable business model
buy
Molecular Templates Inc.

Start price
Target price
Perf. (%)
€2.76
23.01.22
-
23.01.23
-8.12%
06.02.22

Risky Investment
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€14.52
23.01.22
-
23.01.23
7.06%
06.02.22

Could be worthwhile Investment >10% per year
buy
Geron Corp.

Start price
Target price
Perf. (%)
€0.89
23.01.22
€5.00
23.01.24
129.79%
17.09.23

Very Future proof/growth oriented business model
Strong uniques
Could be very worthwhile Investment >20% year
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.30
23.01.22
-
23.01.23
15.82%
06.02.22

Risky Investment
buy
Valneva SE

Start price
Target price
Perf. (%)
€15.90
23.01.22
-
23.01.23
-5.47%
06.02.22

Could be very worthwhile Investment >20% year
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€74.55
23.01.22
-
23.01.23
7.12%
06.02.22

Could be very worthwhile Investment >20% year
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€137.00
23.01.22
-
23.01.23
4.37%
06.02.22

Could be very worthwhile Investment >20% year
buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€6.43
23.01.22
-
23.01.23
7.21%
06.02.22

Could be very worthwhile Investment >20% year
buy
Marathon Digital Holdings

Start price
Target price
Perf. (%)
€19.32
23.01.22
-
23.01.23
18.79%
06.02.22

Risky Investment
Siemens Energy AG

Start price
Target price
Perf. (%)
€19.40
23.01.22
€18.00
23.01.23
-40.75%
26.09.22

buy
Netflix Inc.

Start price
Target price
Perf. (%)
€355.00
23.01.22
-
23.01.23
-49.02%
15.05.22

Could be worthwhile Investment >10% per year
buy
Netflix Inc.

Start price
Target price
Perf. (%)
€355.00
23.01.22
-
23.01.23
-49.02%
15.05.22

Could be worthwhile Investment >10% per year
buy
Netflix Inc.

Start price
Target price
Perf. (%)
€355.00
23.01.22
-
23.01.23
-49.02%
15.05.22

Could be worthwhile Investment >10% per year
buy
Gamesa Corp.

Start price
Target price
Perf. (%)
€16.75
23.01.22
-
23.01.23
2.57%
09.02.22

Could be worthwhile Investment >10% per year
buy
Siemens Energy AG

Start price
Target price
Perf. (%)
€19.40
23.01.22
-
23.01.23
7.84%
08.03.22

Could be worthwhile Investment >10% per year
Fair valuation
buy
NN Group NV

Start price
Target price
Perf. (%)
€48.90
22.01.22
€52.00
22.01.23
-20.16%
23.01.23

Could be worthwhile Investment >10% per year
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€137.00
22.01.22
€165.00
22.01.23
4.37%
06.02.22

Revenue growth >5% per year expected
Differentiated customer and product portfolio
Future proof or reliable business model
Higher risks for its business
buy
Pierre & Vacances S.A.

Start price
Target price
Perf. (%)
€7.06
22.01.22
-
22.01.23
-88.74%
23.09.22

Could be worthwhile Investment >10% per year
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€139.80
21.01.22
€160.00
21.01.23
-2.00%
22.01.22

Revenue growth >5% per year expected
Differentiated customer and product portfolio
Future proof or reliable business model
Higher risks for its business